Modular Medical, Inc.
MODD
$0.8733
-$0.0257-2.86%
| Weiss Ratings | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.28 | |||
| Price History | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.49% | |||
| 30-Day Total Return | -31.24% | |||
| 60-Day Total Return | -42.55% | |||
| 90-Day Total Return | -60.84% | |||
| Year to Date Total Return | -38.06% | |||
| 1-Year Total Return | -57.61% | |||
| 2-Year Total Return | -51.48% | |||
| 3-Year Total Return | -77.02% | |||
| 5-Year Total Return | 21.29% | |||
| 52-Week High % Change | -67.05% | |||
| 52-Week Low % Change | 28.43% | |||
| Price | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.65 | |||
| 52-Week Low Price | $0.68 | |||
| 52-Week Low Price (Date) | Mar 03, 2025 | |||
| 52-Week High Price (Date) | Sep 05, 2024 | |||
| Valuation | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 35.51M | |||
| Enterprise Value | 29.44M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.55 | |||
| Earnings Per Share Growth | -40.95% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 3.46 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.87 | |||
| Enterprise Value/EBITDA (TTM) | -1.68 | |||
| Enterprise Value/EBIT | -1.60 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 37.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (858) 800-3500 | |||
| Address | 10740 Thornmint Road San Diego, CA 92127 | |||
| Website | www.modularmedical.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -125.28% | |||
| Return on Equity | -- | |||
| Income Statement | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -17.51M | |||
| EBIT (TTM) | -18.39M | |||
| Net Income (TTM) | -18.18M | |||
| Net Income Avl. to Common (TTM) | -18.18M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 8.83% | |||
| EPS Diluted (TTM) | -0.55 | |||
| EPS Diluted Growth (Q YOY) | 45.64% | |||
| Balance Sheet | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.99M | |||
| Cash Per Share (Q) | $0.18 | |||
| Total Current Assets (Q) | 7.33M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.26M | |||
| Current Ratio (Q) | 5.301 | |||
| Book Value Per Share (Q) | $0.25 | |||
| Total Assets (Q) | 12.15M | |||
| Total Current Liabilities (Q) | 1.38M | |||
| Total Debt (Q) | 914.00K | |||
| Total Liabilities (Q) | 1.89M | |||
| Total Common Equity (Q) | 10.26M | |||
| Cash Flow | MODD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.03M | |||
| Cash from Financing (TTM) | 21.88M | |||
| Net Change in Cash (TTM) | 4.94M | |||
| Levered Free Cash Flow (TTM) | -10.04M | |||
| Cash from Operations (TTM) | -14.91M | |||
